Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real‐World Database
Liver International · 2025
DOI: 10.1111/liv.70336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Alessandro Loglio und 49 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology, Hepatology and Transplantation Division, ASST Papa Giovanni XXIII, Bergamo, Italy. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis D, Chronic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gilead Sciences.
Abstract (Originalsprache)
Background and Aims Hepatitis B (HBV) and Hepatitis Delta virus (HDV) infection have undergone significant changes in Italy over the past few decades, but reliable and updated prevalence of chronic hepatitis B (CHB) and Delta (CHD) data are lacking. The aim of the study was to describe the epidemiology of CHB and CHD in Italy in 2024, based on real‐world data.
Methods
The number of patients with a healthcare expenditure exemption for CHB (016.070.32) and CHD (016.070.33) was obtained from 21 Regional Health Authorities. To understand how many CHB or CHD patients did not have these specific exemptions, a survey was conducted in 30 Gastroenterology, Hepatology and Infectious Diseases Units across the country.
Results
Health Authorities data reported 67 514 and 5216 subjects with an exemption for CHB and for CHD, respectively. However, among 6775 CHB and 504 CHD patients, only 60.3% and 55.7% of them had the specific exemption, respectively. Based on these results, we estimated 111 960 (95% CI: 109 780–114 240) CHB and 9360 (95% CI: 8690–10 150) CHD patients, with a prevalence of 0.22% and 0.019% of the adult overall population. Moreover, anti‐HDV prevalence was 7.7% from this cohort.
Conclusion
Our study provides a plausible estimate of the current number of adult patients diagnosed with CHB and CHD in Italy and may be considered the basis for decision‐making health policies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology, Hepatology and Transplantation Division, ASST Papa Giovanni XXIII, Bergamo, Italy.
- EpaC Ets, Italian Liver Patient Association, Monza, Italy.
- Unit of Hepatology and Interventional Ultrasonography, Department of Internal Medicine, OORR Area Stabiese, Gragnano, Italy.
- Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
- Liver Injury and Transplant Unit, Azienda Ospedaliero-Universitaria Delle Marche, Ancona, Italy.
- Department of Clinical Medicine and Surgery, University of Napoli Federico II, Naples, Italy.
ORCID-Profile: Alessandro Loglio, Gianluca Svegliati-Baroni, Laura Schiadà, Ivan Gentile, Biagio Pinchera, Maurizia Rossana Brunetto, Alessio Aghemo, Pierluigi Toniutto, Edoardo Giovanni Giannini, Antonio Colecchia, Dante Romagnoli, Loredana Sarmati, Francesca Romana Ponziani, Filomena Morisco, Giuseppe Cabibbo, Pietro Lampertico, Elisabetta Degasperi, Pietro Invernizzi, Antonio Ciaccio, Antonio Massimo Ippolito, Grazia Anna Niro, Gerardo Nardone, Alba Rocco, David Sacerdoti, Alessandro Federico, Vincenzo Messina, Ernesto Claar, Valerio Rosato, Gianpiero D'Offizi, Paolo Caraceni, Paolo Muratori, Stefano Fagiuoli, Mauro Viganò
Förderung
- Gilead Sciences
Zitieren
APA
Loglio, A., Gardini, I., Conforti, M., Bartoli, M., Silvia, F., Coppola, C., Chessa, L., Svegliati-Baroni, G., Schiadà, L., Gentile, I., Pinchera, B., Brunetto, M. R., Colombatto, P., Aghemo, A., De Nicola, S., Toniutto, P., Giannini, E. G., Colecchia, A., Romagnoli, D., …, & Viganò, M. (2025). Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real‐World Database. Liver International. https://doi.org/10.1111/liv.70336
Vancouver
Loglio A, Gardini I, Conforti M, Bartoli M, Silvia F, Coppola C, et al. Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real‐World Database. Liver International. 2025. doi:10.1111/liv.70336
BibTeX
@article{Loglio2025,
author = {Loglio, Alessandro and Gardini, Ivan and Conforti, Massimiliano and Bartoli, Marco and Silvia, Francesco and Coppola, Carmine and Chessa, Luchino and Svegliati-Baroni, Gianluca and Schiadà, Laura and Gentile, Ivan and Pinchera, Biagio and Brunetto, Maurizia Rossana and Colombatto, Piero and Aghemo, Alessio and De Nicola, Stella and Toniutto, Pierluigi and Giannini, Edoardo Giovanni and Colecchia, Antonio and Romagnoli, Dante and Sarmati, Loredana and Ponziani, Francesca Romana and Morisco, Filomena and Cammà, Calogero and Cabibbo, Giuseppe and Lampertico, Pietro and Degasperi, Elisabetta and Invernizzi, Pietro and Ciaccio, Antonio and Russo, Francesco Paolo and Ippolito, Antonio Massimo and Niro, Grazia Anna and Terreni, Natalia and Nardone, Gerardo and Rocco, Alba and D'Antò, Maria and Sacerdoti, David and Ieluzzi, Donatella and Ciancio, Alessia and Pellicelli, Adriano and Federico, Alessandro and Simone, Loredana and Messina, Vincenzo and Claar, Ernesto and Rosato, Valerio and D'Offizi, Gianpiero and Caraceni, Paolo and Muratori, Paolo and Giaccherini, Cinzia and Fagiuoli, Stefano and Viganò, Mauro},
title = {Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real‐World Database},
journal = {Liver International},
year = {2025},
doi = {10.1111/liv.70336}
}
EUVIMED